Status:
UNKNOWN
The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Endometrial Carcinoma
Lymphadenectomy
Eligibility:
FEMALE
10-90 years
Phase:
NA
Brief Summary
The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for end...
Detailed Description
The clinical data including surgical procedure, the situation of sentinel lymph node imaging and pathological results of patients with endometrial carcinoma treated in our hospitals between April 2019...
Eligibility Criteria
Inclusion
- Females who are diagnosed with endometrial carcinoma;
- Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
- Patients who are agreed to participated in this prospective cohort study.
Exclusion
- Patients who still have the will to have pregnancy;
- Patients who have other diseases or heavy injuries that will interfere with the results;
- Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03877627
Start Date
April 1 2022
End Date
April 1 2023
Last Update
October 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.